Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovodak in Hepatitis C (SD1000)
NCT03200184Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sofosbuvir and daclatasvir in hepatitis C (HCV), sponsored by Tehran University of Medical Sciences. Primary endpoint: Sustained Viral Response. Started Sep 2016; status: completed.
02
Drugs
sofosbuvirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03200184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200184.